27 related articles for article (PubMed ID: 8535215)
1. Soluble ICAM-1 in breast cancer: clinical significance and biological implications.
Köstler WJ; Tomek S; Brodowicz T; Budinsky AC; Flamm M; Hejna M; Krainer M; Wiltschke C; Zielinski CC
Cancer Immunol Immunother; 2001 Nov; 50(9):483-90. PubMed ID: 11761443
[TBL] [Abstract][Full Text] [Related]
2. Retracted: Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer.
Intelligence And Neuroscience C
Comput Intell Neurosci; 2023; 2023():9859267. PubMed ID: 37800020
[TBL] [Abstract][Full Text] [Related]
3. Stromal regulation of embryonic and postnatal mammary epithelial development and differentiation.
Howard BA; Lu P
Semin Cell Dev Biol; 2014; 25-26():43-51. PubMed ID: 24445189
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9 expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in young adult patients with classical Hodgkin lymphoma.
Campos AH; Vassallo J; Soares FA
PLoS One; 2013; 8(9):e74793. PubMed ID: 24086377
[TBL] [Abstract][Full Text] [Related]
5. Intercellular adhesion molecule 1: recent findings and new concepts involved in mammalian spermatogenesis.
Mruk DD; Xiao X; Lydka M; Li MW; Bilinska B; Cheng CY
Semin Cell Dev Biol; 2014 May; 29():43-54. PubMed ID: 23942142
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas.
Shah N; Cabanillas F; McIntyre B; Feng L; McLaughlin P; Rodriguez MA; Romaguera J; Younes A; Hagemeister FB; Kwak L; Fayad L
Leuk Lymphoma; 2012 Jan; 53(1):50-6. PubMed ID: 21895545
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in pediatric Hodgkin disease.
Schwartz CL
Curr Oncol Rep; 2003 Nov; 5(6):498-504. PubMed ID: 14521809
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma.
Hoffmann R; Franzke A; Buer J; Sel S; Oevermann K; Duensing A; Probst M; Duensing S; Kirchner H; Ganser A; Atzpodien J
Br J Cancer; 1999 Apr; 79(11-12):1742-5. PubMed ID: 10206286
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage.
Grothey A; Heistermann P; Philippou S; Voigtmann R
Br J Cancer; 1998 Mar; 77(5):801-7. PubMed ID: 9514061
[TBL] [Abstract][Full Text] [Related]
10. Biopathologic features of Hodgkin's disease.
Chilosi M; Pizzolo G
Leuk Lymphoma; 1995 Feb; 16(5-6):385-95. PubMed ID: 7787748
[TBL] [Abstract][Full Text] [Related]
11. Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review.
Gu X; Ma C; Yuan D; Song Y
Transl Lung Cancer Res; 2012 Mar; 1(1):36-44. PubMed ID: 25806153
[TBL] [Abstract][Full Text] [Related]
12. Soluble ICAM-1 in Hodgkin's disease: a promising independent predictive marker for survival.
Christiansen I; Enblad G; Kälkner KM; Gidlöf C; Glimelius B; Tötterman TH
Leuk Lymphoma; 1995 Oct; 19(3-4):243-51. PubMed ID: 8535215
[TBL] [Abstract][Full Text] [Related]
13. Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease.
Christiansen I; Sundström C; Enblad G; Tötterman TH
Br J Haematol; 1998 Aug; 102(3):701-9. PubMed ID: 9722296
[TBL] [Abstract][Full Text] [Related]
14. Soluble molecules as biological markers in Hodgkin's disease.
Nadali G; Vinante F; Chilosi M; Pizzolo G
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():99-105. PubMed ID: 9570686
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers.
Christiansen I; Gidlof C; Kälkner K M; Hagberg H; Bennmarker H; Tötterman T
Br J Haematol; 1996 Mar; 92(3):639-46. PubMed ID: 8616029
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
